Bone Metabolism Adjacent to Hip Prosthetic Surfaces. A Clinical F-PET/CT Study
NCT ID: NCT02320682
Last Updated: 2018-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
32 participants
INTERVENTIONAL
2014-12-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Imaging of Joint Replacement Complications by PET/CT
NCT01970228
CT-based 3D Planning, Computer Navigation and Subsequent Migration Analysis in Total Hip Arthroplasty
NCT05159206
Ceramic-on-ceramic THA for Post-traumatic Hip Osteoarthritis After Acetabular Fracture
NCT04034043
THA Kinematics and Sound for Subjects for Normal, Diseased and Implanted Hips
NCT02682602
Periprosthetic Bone Mineral Density Changes After Implantation Of A Short Hip Stem Compared To A Straight Stem
NCT03147131
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Intervention will be surgery with a total hip arthroplasty. The four studied endoprosthetic components are:
* Cemented Exeter stem (Stryker Warsaw, USA) with a ceramic 32 mm head and Palacose cement with gentamycin, applied with 3:rd generation cementation technique.
* Uncemented Lubinus SP-CL stem (Waldemar Link, Hamburg, Germany) with a ceramic 32 mm head.
* Uncemented Delta PF cup (Limacorporate spa, Udine, Italy).
* Uncemented fibrous metal Delta TT cup (Limacorporate spa, Udine, Italy). Both cups will have cross linked Ultra-high-molecular-weight polyethylene (UHWMP).
Clinical score, radiography and uptake of Fluoride tracer will be analyzed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exeter femur component and Delta TT acetabular component
Surgery for Total Hip Arthroplasty (THA)
THA surgery where four prosthetic components will randomly be inserted. Randomly an Exeter or SP-CL femur component will be combined with randomly a Delta TT or Delta PF acetabular component.
SP-CL femur component and Delta TT acetabular component
Surgery for Total Hip Arthroplasty (THA)
THA surgery where four prosthetic components will randomly be inserted. Randomly an Exeter or SP-CL femur component will be combined with randomly a Delta TT or Delta PF acetabular component.
SP-CL femoral component and Delta PF acetabular component
Surgery for Total Hip Arthroplasty (THA)
THA surgery where four prosthetic components will randomly be inserted. Randomly an Exeter or SP-CL femur component will be combined with randomly a Delta TT or Delta PF acetabular component.
Exeter femoral component and Delta PF acetabular component
Surgery for Total Hip Arthroplasty (THA)
THA surgery where four prosthetic components will randomly be inserted. Randomly an Exeter or SP-CL femur component will be combined with randomly a Delta TT or Delta PF acetabular component.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgery for Total Hip Arthroplasty (THA)
THA surgery where four prosthetic components will randomly be inserted. Randomly an Exeter or SP-CL femur component will be combined with randomly a Delta TT or Delta PF acetabular component.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
50 Years
69 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
gosta ullmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
gosta ullmark
Assistent Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gösta Ullmark, MD
Role: PRINCIPAL_INVESTIGATOR
Orthopaedic department Gävle hospital, Gävle, Sweden and Centre for Research & Development Uppsala University/County Council of Gävleborg.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orthopaedic department Gävle hospital
Gävle, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sotiriou D, Sorensen J, Ullmark G. [18F]-fluoride PET/CT analyses of postoperative bone mineralisation adjacent to femoral stems at THA: a randomised clinical trial. Hip Int. 2025 Sep 30:11207000251372025. doi: 10.1177/11207000251372025. Online ahead of print.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Fingerprint III
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.